Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2017 | Moving in the right direction: new possibilities in lymphoma

Wojciech Jurczak • 22 Jun 2017
EHA 2017

Despite there being no ‘breakthrough’ news during June 2017 at the major conferences – ASCO, ICML and EHA – we are making progress. Prof. Wojciech Jurczak from Jagiellonian University, Krakow, Poland, describes the positive steps we’re making for the treatment of lymphomas.

More from Wojciech Jurczak

Nemtabrutinib in R/R follicular lymphoma
1:13
Nemtabrutinib in R/R follicular lymphoma
Wojciech Jurczak • 6 Dec 2025
Bexobrutideg in CLL and approaching the sequencing of BTK degraders and inhibitors
2:20
Bexobrutideg in CLL and approaching the sequencing of BTK degraders and inhibitors
Wojciech Jurczak • 6 Dec 2025
BRUIN CLL-313 results: pirtobrutinib versus BR in patients with treatment-naive CLL/SLL
5:17
BRUIN CLL-313 results: pirtobrutinib versus BR in patients with treatment-naive CLL/SLL
Wojciech Jurczak • 6 Dec 2025
Treating R/R CLL: the value of BTKis and venetoclax
1:59
Treating R/R CLL: the value of BTKis and venetoclax
Wojciech Jurczak • 27 Sep 2024
The content of VJHemOnc is intended for healthcare professionals